Nebraska — drug testing employment law

At a glance: Nebraska

Overview: drug testing in Nebraska

Nebraska's private-sector testing landscape is broadly permissive, with limited substantive statutory restrictions. The 2024 ballot initiatives (Initiative 437 and 438) authorizing a medical cannabis program have created a regulatory regime in implementation, but the legal landscape remains unsettled as of the most recent review. Recreational cannabis remains illegal.

Cannabis law and workplace testing

The 2024 medical cannabis initiatives are being implemented and litigated. As currently structured, the initiatives do not contain comprehensive employment anti-discrimination provisions. Recreational use remains illegal.

Specific testing rules in Nebraska

The table below summarizes how Nebraska typically treats four common workplace testing scenarios. Each row reflects the dominant statutory or case-law position; carve-outs (federal-contractor, DOT-regulated, safety-sensitive, etc.) may shift any individual analysis.

Federal overlay: DOT and federal contractors

In all U.S. states — including Nebraska — DOT-regulated employees (safety-sensitive roles in transportation industries under 49 CFR Part 40) and federal-contractor employees subject to the federal Drug-Free Workplace Act of 1988 are testable under federal rules regardless of state cannabis status or workplace-testing restrictions. State law cannot reduce federal testing obligations for these populations. Where state law otherwise restricts cannabis testing, the federal-overlay carve-out typically preserves the employer's authority for these federally affected roles.

For employers in Nebraska

Nebraska employers have broad testing discretion. Monitor the implementation of the 2024 medical cannabis initiatives for any subsequent employment-law amendments. Cannabis remains testable across the workforce.

• Written policy. Document the substances tested, the cutoff levels, the testing modalities (urine / oral fluid / hair), and the consequences of a non-negative result.
• Notice. Provide written notice before testing begins and obtain signed acknowledgement where the state requires it.
• Certified laboratory. Use a SAMHSA-certified or equivalent laboratory; document chain of custody.
• Confirmation testing. Confirm any non-negative initial result with mass-spectrometry (GC-MS or LC-MS/MS) before any adverse action.
• MRO review. Engage a qualified Medical Review Officer to review all non-negative results before reporting to the employer.
• Safety-sensitive designations. If the role is statutorily exempt as safety-sensitive, document the designation in writing using the state\'s statutory definition.
• Medical cannabis disclosures. Where state law provides patient protection, engage an interactive accommodation process before adverse action.

For workers in Nebraska

Nebraska currently provides no statutory employment protection for cannabis use, including the newly authorized medical use. The legal landscape is in flux — monitor implementation for any changes.

• Know the policy. Request a copy of your employer\'s written testing policy — it should specify when testing occurs, what is tested, and how to challenge a result.
• Disclose medications to the MRO, not the employer. The Medical Review Officer reviews non-negative results before they are reported and can resolve a legitimate prescription explanation.
• Document medical cannabis status. If you are a registered medical cannabis patient in a state with patient protection, document your status with HR before testing.
• Confirmation testing. Any non-negative initial result should be confirmed by GC-MS or LC-MS/MS before adverse action.
• Appeal rights. Many state statutes provide an appeals process — read your employer\'s policy carefully.

Key statutes and citations

The following statutory citations are the primary controlling authority for drug testing employment law in Nebraska. We provide citations only — confirm current text via your state legislature\'s codified statutes (or an authoritative legal research platform) before relying on this information.

• Private-sector testing baseline — Neb. Rev. Stat. § 48-1901 et seq.
• Medical Cannabis Act (2024 initiatives 437 & 438) — Neb. Rev. Stat. § 28-475 (pending implementation)

Multi-state employers operating in Nebraska

A national or multi-state employer\'s policy that works in a permissive state (e.g., Alabama or Texas) may not be lawful as applied to employees in Nebraska, and vice versa. Common multi-state pitfalls include: applying a national pre-employment cannabis screen in jurisdictions that prohibit it; treating a positive cannabis test as automatic disqualification where state law restricts that outcome; failing to designate safety-sensitive roles in compliance with the relevant state\'s statutory definition; and not maintaining state-specific written policies and acknowledgements. For multi-state programs, see our multi-state employer guide.

How this page is built and reviewed

This page combines a structured data layer (cannabis status, statutory protection levels, voluntary program details, statute citations) with state-specific narrative drafted from primary statutes and authoritative secondary sources. Every claim should trace either to a statute citation, an authoritative secondary source (e.g., NCSL, EEOC, DOT, SHRM, ASAM), or general background knowledge clearly framed as such. The page is reviewed against the listed sources on each material amendment.

Found something out of date? Let us know — we update state pages as statutes and case law evolve.